LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer

American Journal of Translational Research

Volumn 8, Issue 11, 2016, Pages 5035-5043

  Zhang, Yuanyuan ^a   Yang, Rui ^b   Lian, Jianchun ^a   Xu, Haiyan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Fifth Hospital of Wuhan   (China)

Author keywords

Biomarker; Gastric cancer; lncRNA; Sox2ot

Indexed keywords

BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; TRANSCRIPTION FACTOR SOX2;

ADULT; ARTICLE; CANCER PROGNOSIS; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL MOTILITY; CELL PROLIFERATION; CLINICAL FEATURE; COLONY FORMATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MTT ASSAY; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR GROWTH;

EID: 84998890579     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
2. Siegel RL, Miller KD and Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
3. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L and He J. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 2013; 32: 106-112.
4. Pasechnikov V, Chukov S, Fedorov E, Kikuste I and Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol 2014; 20: 13842-13862.
5. Yoon H and Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver 2015; 9: 5-17.
6. Sun M, Nie FQ, Wang ZX and De W. Involvement of lncRNA dysregulation in gastric cancer. Histol Histopathol 2016; 31: 33-39.
7. Zhao J, Liu Y, Huang G, Cui P, Zhang W and Zhang Y. Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am J Cancer Res 2015; 5: 907-927.
8. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J and Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279: 3159-3165.
9. Zhuang M, Gao W, Xu J, Wang P and Shu Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448: 315-322.
10. Zhang EB, Han L, Yin DD, Kong R, De W and Chen J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol 2014; 31: 914.
11. Li H, Yu B, Li J, Su L, Yan M, Zhu Z and Liu B. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 2014; 5: 2318-2329.
12. Sun M, Xia R, Jin F, Xu T, Liu Z, De W and Liu X. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol 2014; 35: 1065-1073.
13. Peng W, Si S, Zhang Q, Li C, Zhao F, Wang F, Yu J and Ma R. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer Res 2015; 34: 79.
14. Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, Xia R, Wan L, Sun M, Wang ZX, De W and Zhang ZH. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer 2015; 14: 82.
15. Ding J, Li D, Gong M, Wang J, Huang X, Wu T and Wang C. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther 2014; 7: 1625-1630.
16. Li L, Zhang L, Zhang Y and Zhou F. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother 2015; 72: 109-112.
17. Liu Z, Shao Y, Tan L, Shi H, Chen S and Guo J. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol 2014; 35: 9613-9617.
18. Sarkaria I, P Oc, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, Kaufman A, Ryan R, Ghossein R, Rao PH, Stoffel A, Ramanathan Y and Singh B. Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res 2006; 66: 9437-9444.
19. Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembele D, Martinet N, Thibault C, Huelsken J, Brambilla E and du Manoir S. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 2010; 5: e8960.
20. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K, van Heyningen V and FitzPatrick DR. Mutations in SOX2 cause anophthalmia. Nat Genet 2003; 33: 461-463.
21. Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E, Brohee S, Salmon I, Dubois C, del Marmol V, Fuks F, Beck B and Blanpain C. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 2014; 511: 246-250.
22. Shahryari A, Jazi MS, Samaei NM and Mowla SJ. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet 2015; 6: 196.
23. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M and La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 666-673.
24. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-386.
25. Tian SB, Yu JC, Kang WM, Ma ZQ, Ye X, Cao ZJ and Yan C. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Asian Pac J Cancer Prev 2014; 15: 6295-6300.
26. Zhou YC, Zhao HJ and Shen LZ. Preoperative serum CEA and CA19-9 in gastric cancer--a single tertiary hospital study of 1,075 cases. Asian Pac J Cancer Prev 2015; 16: 2685-2691.
27. Ponting CP, Oliver PL and Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
28. Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui P, Zhang Y and Huang G. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer. Cell Cycle 2015; 14: 3112-3123.
29. Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, Xiao B and Guo J. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol 2014; 35: 5441-5447.
30. Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, Wang B, Ye G, Xiao B and Guo J. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol 2015; 36: 2007-2012.
31. Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and Goel A. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014; 35: 2731-2739.
32. Wang J, Su L, Chen X, Li P, Cai Q, Yu B, Liu B, Wu W and Zhu Z. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother 2014; 68: 557-564.
33. Shi XM and Teng F. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Int J Clin Exp Pathol 2015; 8: 4008-4014.
34. Shahryari A, Rafiee MR, Fouani Y, Oliae NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma. Stem Cells 2014; 32: 126-134.
35. Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu C, Chang C, Bi H, Zou J, Yao X, Huang R, Yu L and Yan J. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival. Int J Biochem Cell Biol 2014; 53: 380-388.
36. Askarian-Amiri ME, Seyfoddin V, Smart CE, Wang J, Kim JE, Hansji H, Baguley BC, Finlay GJ and Leung EY. Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer. PLoS One 2014; 9: e102140.
37. Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S. Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol 2015; 37: 2933-40.